HIT Consultant August 7, 2024
Jasmine Pennic

What You Should Know:

Phenomix Sciences, a precision medicine biotechnology company, released findings from a new survey revealing a growing demand for personalized obesity care.

– The survey of 475 patients explored attitudes toward weight management, treatment preferences, and information sources.

Key Findings:

  • Patients Seek Medical Guidance: A majority of respondents (66%) prefer guidance from healthcare providers to manage weight loss, highlighting the need for a more clinical approach to obesity treatment.
  • Desire for Personalized Care: Nearly two-thirds of patients expressed interest in genetic testing to tailor obesity interventions, emphasizing the growing importance of personalized medicine.
  • Influence of Social Media: While social media is a primary source of information about weight loss medications like GLP-1s, only...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Patient / Consumer, Pharma / Biotech, Precision Medicine, Provider, Survey / Study, Trends
Advancing Cancer Care: The Role of Radiopharmaceuticals in Precision Medicine
Exploring Precision Medicine and PGx: Sara Rogers, PharmD, Previews Precision Medicine World Conference 2025
India targets to sequence 10 million genomes
23andMe considers sale as cash runs low
23andMe considers a sale as cash runs low

Share This Article